Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Department of Pathology, Texas Children's Hospital, Houston, TX, USA.
Physiol Rep. 2021 Jan;9(2):e14719. doi: 10.14814/phy2.14719.
BACKGROUND: Lactic acid bacteria are commensal members of the gut microbiota and are postulated to promote host health. Secreted factors and cell surface components from Lactobacillus species have been shown to modulate the host immune system. However, the precise role of L. reuteri secreted factors and surface proteins in influencing dendritic cells (DCs) remains uncharacterized. HYPOTHESIS: We hypothesize that L. reuteri secreted factors will promote DC maturation, skewing cells toward an anti-inflammatory phenotype. In acute colitis, we speculate that L. reuteri promotes IL-10 and dampens pro-inflammatory cytokine production, thereby improving colitis. METHODS & RESULTS: Mouse bone marrow-derived DCs were differentiated into immature dendritic cells (iDCs) via IL-4 and GM-CSF stimulation. iDCs exposed to L. reuteri secreted factors or UV-irradiated bacteria exhibited greater expression of DC maturation markers CD83 and CD86 by flow cytometry. Additionally, L. reuteri stimulated DCs exhibited phenotypic maturation as denoted by cytokine production, including anti-inflammatory IL-10. Using mouse colonic organoids, we found that the microinjection of L. reuteri secreted metabolites and UV-irradiated bacteria was able to promote IL-10 production by DCs, indicating potential epithelial-immune cross-talk. In a TNBS-model of acute colitis, L. reuteri administration significantly improved histological scoring, colonic cytokine mRNA, serum cytokines, and bolstered IL-10 production. CONCLUSIONS: Overall these data demonstrate that both L. reuteri secreted factors and its bacterial components are able to promote DC maturation. This work points to the specific role of L. reuteri in modulating intestinal DCs. NEW & NOTEWORTHY: Lactobacillus reuteri colonizes the mammalian gastrointestinal tract and exerts beneficial effects on host health. However, the mechanisms behind these effects have not been fully explored. In this article, we identified that L. reuteri ATTC PTA 6475 metabolites and surface components promote dendritic cell maturation and IL-10 production. In acute colitis, we also demonstrate that L. reuteri can promote IL-10 and suppress inflammation. These findings may represent a crucial mechanism for maintaining intestinal immune homeostasis.
背景:乳酸菌是肠道微生物群的共生成员,据推测可促进宿主健康。已表明,来自乳杆菌属的分泌因子和细胞表面成分可调节宿主免疫系统。然而,L. reuteri 分泌因子和表面蛋白在影响树突状细胞(DC)方面的确切作用仍未被描述。
假设:我们假设 L. reuteri 分泌因子将促进 DC 成熟,使细胞向抗炎表型倾斜。在急性结肠炎中,我们推测 L. reuteri 促进 IL-10 的产生并抑制促炎细胞因子的产生,从而改善结肠炎。
方法和结果:通过 IL-4 和 GM-CSF 刺激从小鼠骨髓中分化出未成熟的树突状细胞(iDC)。通过流式细胞术检测到,暴露于 L. reuteri 分泌因子或紫外线照射细菌的 iDC 表达更高的 DC 成熟标志物 CD83 和 CD86。此外,L. reuteri 刺激的 DC 表现出表型成熟,表现为细胞因子产生,包括抗炎性的 IL-10。使用小鼠结肠类器官,我们发现 L. reuteri 分泌代谢物和紫外线照射细菌的微注射能够促进 DC 产生 IL-10,表明潜在的上皮-免疫交叉对话。在 TNBS 诱导的急性结肠炎模型中,L. reuteri 给药可显著改善组织学评分、结肠细胞因子 mRNA、血清细胞因子,并增强 IL-10 的产生。
结论:总的来说,这些数据表明,L. reuteri 的分泌因子及其细菌成分均能够促进 DC 成熟。这项工作指出了 L. reuteri 在调节肠道 DC 中的特定作用。
新的和值得注意的:乳酸菌定植于哺乳动物胃肠道,并对宿主健康产生有益影响。然而,这些影响背后的机制尚未完全探索。在本文中,我们发现 L. reuteri ATTC PTA 6475 代谢物和表面成分可促进树突状细胞成熟和 IL-10 的产生。在急性结肠炎中,我们还证明 L. reuteri 可以促进 IL-10 的产生并抑制炎症。这些发现可能代表维持肠道免疫稳态的关键机制。
Microorganisms. 2024-12-30
Vet Med (Praha). 2024-8-29
MedComm (2020). 2024-6-29
Discov Immunol. 2023-10-7
Clin Exp Immunol. 2024-9-16
Front Microbiol. 2019-10-9
Cell Mol Gastroenterol Hepatol. 2019-4-25
Front Microbiol. 2018-4-19
Microbiol Spectr. 2017-10
Am J Physiol Gastrointest Liver Physiol. 2017-11-1
Clin Exp Immunol. 2017-6